Gan & Lee Pharmaceuticals. (SHA:603087)
72.42
-0.27 (-0.37%)
Sep 18, 2025, 2:45 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 43.29 billion as of September 18, 2025. Its market cap has increased by 73.30% in one year.
Market Cap
43.29B
Enterprise Value
41.06B
Revenue
3.80B
Ranking
n/a
PE Ratio
46.97
Stock Price
72.42
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 43.29B, an increase of 18.38%. That is a compound annual growth rate of 3.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 43.28B | 64.37% |
Dec 31, 2024 | 26.33B | -15.24% |
Dec 29, 2023 | 31.07B | 68.57% |
Dec 30, 2022 | 18.43B | -53.34% |
Dec 31, 2021 | 39.50B | -46.80% |
Dec 31, 2020 | 74.25B | 103.01% |
Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 473.19B |
WuXi AppTec | 312.41B |
Shenzhen Mindray Bio-Medical Electronics | 287.59B |
Sichuan Biokin Pharmaceutical | 152.38B |
Shanghai United Imaging Healthcare | 123.00B |
Zhangzhou Pientzehuang Pharmaceutical., | 120.66B |
Aier Eye Hospital Group | 119.73B |
Yunnan Baiyao Group Co.,Ltd | 104.36B |